Dr. Ronald Sokol’s life work revolves around the research and treatment of childhood liver diseases and other pediatric disorders.
This safety-themed edition of BioSupply Trends Quarterly addresses this patient safety and how it can be improved.
Major depressive disorder is a prevalent condition, but with swift and
appropriate treatment, the chance of recurrence can be minimized.
Mark Harris, PhD, is the founder and chief executive officer of NextGxDx, a healthcare information company that provides a web-based genetic diagnostics marketplace.
The stigma of depression left Deborah Gray suffering for 20 years with MDD before she was diagnosed.
Prior to penicillin, life expectancy was limited for patients with X-linked agammaglobulinemia. Thanks to the advent of intravenous immune globulin, the prognosis today is much more promising.
The Johnsons look like a picture-perfect family, but behind the smiles, this family faces the daily challenges, heartbreak and loss that come with a diagnosis of primary immunodeficiency
In this plasma-themed issue of BioSupplyTrends Quarterly, we take a critical look at each of these segments of the plasma market.
Kedrion President and CEO Paolo Marcucci discusses Kedrion's goal to strengthen its role as strategic partner of national health systems.
In this issue, we explore novel technologies shaping the future of the healthcare landscape.
David T. Rubin MD, assistant professor of medicine at the University of Chicago Pritzker School of Medicine, is a leading authority on Crohn’s disease and ulcerative colitis.
Tom Robinson refused to passively accept his diagnosis of debilitating Crohn’s disease and instead embarked on a journey that not only restored his health but launched a new career.